Abstract:OBJECTIVE:To investigate the relations between serum homocysteine (Hcy) and folic acid with congenital heart disease (CHD) in CHD nuclear families.METHODS:In Liaoning Province 151 CHD patients and their biological parents were selected as the case group, with another 98 normal subjects and their parents as control. For some filial individuals and their mothers the serum total Hcy (tHcy) levels were detected by fluorescence polarization immunoassay. And for all members the serum levels of folic acid and vitamin B12 (VB12) were determined by radio-immunoassay.RESULTS:There were not significantly differences in the serum tHcy and folic acid levels and theirs abnormality prevalence between CHD patients and the control, neither were their parents in the study. Compared with the control group the serum VB12 levels of CHD patients were apparently higher (315.36 pmol/L and 185.34 pmol/L, P < 0.05), and the VB12 deficiency prevalence of patients and their fathers were lower. Analysis of different CHD types showed that in ventricular septal defect patients the serum tHcy levels were lower than the control with VB12 levels higher, and in parents of patent ductus arteriosus patients the serum folic acid levels were increased (P < 0.05). The study also indicated that the folic acid and VB12 of parents were significantly positively associated with that of filial generation. In the case group the tHcy levels of mothers were positively correlated with filial generation, and in CHD patients the tHcy was negatively associated with folic acid. In filial individuals of the control group the tHcy was negatively related with VB12 (P < 0.05).CONCLUSION:Folic acid and VB12 were important influencing factors of serum Hcy and they were negatively correlated. In this study, the folic acid and Hcy were not significantly related with CHD, and it needs further investigations to confirm it. There were not significant differences in the serum tHcy and folic acid levels and theirs abnormality prevalence between CHD patients and the control, neither were their parents in the study. Compared with the control group the serum VB12 levels of CHD patients were apparently higher (315.36 pmol/L and 185.34 pmol/L, P < 0.05), and the VB12 deficiency prevalence of patients and their fathers were lower. Analysis of different CHD types showed that in ventricular septal defect patients the serum tHcy levels were lower than the control with VB12 levels higher, and in parents of patent ductus arteriosus patients the serum folic acid levels were increased (P < 0.05). The study also indicated that the folic acid and VB12 of parents were significantly positively associated with that of filial generation. In the case group the tHcy levels of mothers were positively correlated with filial generation, and in CHD patients the tHcy was negatively associated with folic acid. In filial individuals of the control group the tHcy was negatively related with VB12 (P < 0.05).CONCLUSION:Folic acid and VB12 were important influencing factors of serum Hcy and they were negatively correlated. In this study, the folic acid and Hcy were not significantly related with CHD, and it needsfurther investigations to confirm it.

CBS gene variations and serum homocysteine level associated with congenital heart defects]

Effects of Cystathionine Beta Synthase Gene Polymorphism in Parents on Occurrence of Congenital Heart Disease in Offsprings

[Study of serum Hcy and polymorphisms of Hcy metabolic enzymes in 192 families affected by congenital heart disease].

Association of maternal dietary intakes and CBS gene polymorphisms with congenital heart disease in offspring

A Functional Variant in the Cystathionine Β-Synthase Gene Promoter Significantly Reduces Congenital Heart Disease Susceptibility in a Han Chinese Population

PC82 STUDY ON SERUM HCY LEVEL AND HCY METABOLISM-RELATED ENZYMES POLYMORPHISMS IN NUCLEAR FAMILIES OF PATIENTS WITH CONGENITAL HEART DISEASE

Correlation Between Rs198388 and Rs198389 Polymorphismsin Brainnatriuretic Peptide (NPPB) Gene and Susceptibility to Congenital Heart Diseases in a Chinese Population.

Mthfr C677t Polymorphism And Risk Of Congenital Heart Defects: Evidence From 29 Case-Control And Tdt Studies

Single Nucleotide Polymorphisms of the S CN5A Gene in Han Chinese and Their Relation with Brugada Syndrome

Genetic Polymorphisms of Homocysteine Metabolism Related Enzymes in Patients with Coronary Heart Disease

Relationship Between Polymorphism of Methylenetetrahydrofolate Dehydrogenase and Congenital Heart Defect.

Association between CBS gene T833C, G919A and 844ins68 polymorphisms in the 8th exon region and coronary artery disease: a meta-analysis

[Relations Between Serum Homocysteine and Folic Acid Levels with Congenital Heart Disease].

Methylenetetrahydrofolate Dehydrogenase G1958A Gene Polymorphism and Congenital Heart Defect Susceptibility

[Effects of Methionine Synthase Gene Variation in Parents on Occurence of Congenital Heart Disease in Offspring].

PS042 Risk Factors Associated with Hyperhomocysteinemia Besides Folate in a Chinese Community-Based Population

Association of fetal congenital heart diseases with methylenetetrahydrofolate reductase gene polymorphisms

Polymorphisms on chromosome 9p21 confer a risk for acute coronary syndrome in a Chinese Han population.

Heterozygous Carriers of Classical Homocystinuria Tend to Have Higher Fasting Serum Homocysteine Concentrations Than Non-Carriers in the Presence of Folate Deficiency.

Effect of parental 5, 10-methylenetetrahydrofolate dehydrogenase genotypes on offspring congenital heart defect risk

Genetic variants reducing MTR gene expression increase the risk of congenital heart disease in Han Chinese populations.